20348-09-8,
2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one,
2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one,
4H-pyrido[3,2-b][1,4]oxazin-3-one,
2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one,
MLS000737540,
2H-Pyrido(3,2-b)-1,4-oxazin-3(4H)-one,
ANHQLUBMNSSPBV-UHFFFAOYSA-N,
MFCD00006697,
2H,4H-pyrido[3,2-b][1,4]oxazin-3-one,
SMR000035346,
2H,4H-pyridino[2,3-e]1,4-oxazin-3-one,
pyridoboxazinone,
EINECS 243-751-1,
NSC122276,
ACMC-20ahw7,
AC1L3FVC,
AC1Q6EUA,
AC1Q1HA9,
Oprea1_736092,
SCHEMBL29569,
MLS000039790,
CHEMBL1370167,
CTK1A6332,
DTXSID00174255,
HMS2426L15,
ZINC155857,
ALBB-014366,
ANW-74117,
SBB006815,
STK526198,
AKOS005071470,
CS-W002009,
LS40780,
MCULE-6251206061,
NSC-122276,
RP09985,
RTR-009479,
TRA0073461,
2H-pyrido[3,2-b][1,4]oxazin-3-one,
AC-23079,
AJ-13637,
AK-81532,
CJ-01457,
EN001390,
SY007983,
ZB006123,
AB0032329,
TR-009479,
2H-pyrido[3,2-b]-1,4-oxazin-3(4H)one,
FT-0612507,
ST50824200,
X5624,
2H-pyrido[3,2-b]-1,4-oxazin-3-(4H)-one,
A-1757,
2H-Pyrido[3,2-b]-1,4-oxazin-3 (4H)-one,
MFCD00006697 (97+%),
348P098,
9Y-0717,
2,3-Dihydro-4H-pyrido[3,2-b][1,4]oxazin-3-one,
J-509566,
2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 95%,
I14-14109,
Z1346385715,
C7H6N2O2,
C7-H6-N2-O2,
CID88499,
AR-1E2152,
20773-28-8,